15 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Watch These 5 Medical Stocks for Q1 Earnings: Beat or Miss? https://www.zacks.com/stock/news/2260507/watch-these-5-medical-stocks-for-q1-earnings-beat-or-miss?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2260507 Apr 23, 2024 - Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.
Molina (MOH) Wins Deal to Serve Michigan's Medicaid Members https://www.zacks.com/stock/news/2254801/molina-moh-wins-deal-to-serve-michigan-s-medicaid-members?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2254801 Apr 12, 2024 - Molina Healthcare (MOH) wins a Medicaid contract from the MDHHS to better care for the healthcare needs of Michigan's Medicaid beneficiaries and therefore, gain more customers.
Centene (CNC) Wins Medicaid Contract to Better Serve Michigan https://www.zacks.com/stock/news/2254020/centene-cnc-wins-medicaid-contract-to-better-serve-michigan?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2254020 Apr 11, 2024 - Centene's (CNC) Meridian secures a contract from the Michigan Department of Health and Human Services, which gives it the opportunity to better serve the health needs of the state's Medicaid members.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings https://www.zacks.com/stock/news/2245867/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245867 Mar 26, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
The Joint (JYNT) to Report Q4 Earnings: Here Are the Key Drivers https://www.zacks.com/stock/news/2236169/the-joint-jynt-to-report-q4-earnings-here-are-the-key-drivers?cid=CS-ZC-FT-analyst_blog|earnings_preview-2236169 Mar 05, 2024 - The Joint's (JYNT) fourth-quarter 2023 results are likely to reflect higher expenses and patient volumes.
3 HMO Stocks in Focus Despite High Tech Costs & Nursing Shortage https://www.zacks.com/commentary/2224560/3-hmo-stocks-in-focus-despite-high-tech-costs-nursing-shortage?cid=CS-ZC-FT-industry_outlook-2224560 Feb 12, 2024 - Growing customer base and M&A strategies are likely to aid the Medical-HMO industry. However, escalating expenses and a dearth in the availability of medical personnel are concerning. Stocks like CI, CNC and MOH are likely to navigate the industry storms.
Stock Market News for Feb 9, 2024 https://www.zacks.com/stock/news/2223900/stock-market-news-for-feb-9-2024?cid=CS-ZC-FT-market_news-2223900 Feb 09, 2024 - Wall Street closed higher on Thursday as strong earnings data boosted market participants??? confidence on risky assets like equities.
Molina Healthcare (MOH) Q4 Earnings Beat on Premium Growth https://www.zacks.com/stock/news/2223634/molina-healthcare-moh-q4-earnings-beat-on-premium-growth?cid=CS-ZC-FT-analyst_blog|earnings_article-2223634 Feb 08, 2024 - Molina Healthcare (MOH) expects adjusted EPS to be at a minimum of $23.5 in 2024, which represents a year-over-year improvement of 12.5%.
Molina (MOH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2222933/molina-moh-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2222933 Feb 07, 2024 - Although the revenue and EPS for Molina (MOH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Gear Up for Molina (MOH) Q4 Earnings: Wall Street Estimates for Key Metrics https://www.zacks.com/stock/news/2220201/gear-up-for-molina-moh-q4-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220201 Feb 02, 2024 - Besides Wall Street's top -and-bottom-line estimates for Molina (MOH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.

Pages: 12

Page 1